Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares Nasdaq Biotechnology ETF (IBB)

BATS BZX Real-Time Price
As of 1:59pm ET
 +5.89 / +1.89%
Today’s Change
Today|||52-Week Range
IBB Regular Dividend: IBB began trading ex-dividend on 06/27/17. A $0.1768 dividend will be paid to shareholders of record as of 06/29/17.

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Vaccine Small-Cap Just Took a Big Step Forward
Jun 26 / GuruFocus News - Paid Partner Content
How President Trump Has Sent Biotech Stocks Soaring
Jun 23 / TheStreet.com - Paid Partner Content
Stocks Mixed as FAANG Stocks Fluctuate, SCOTUS Agrees to Hear Travel Ban
Jun 26 / TheStreet.com - Paid Partner Content
Trader's Daily Notebook: Price Momentum Needs to Stick Around
Jun 23 / TheStreet.com - Paid Partner Content
Stock Futures Point Higher as Healthcare Climbs Ahead of Senate Vote
Jun 26 / TheStreet.com - Paid Partner Content
5 Reasons Why Biotech ETFs are Soaring
Jun 22 / Zacks.com - Paid Partner Content


1 month+10.87% 3 years+7.76%
3 months+10.18% 5 years+20.29%
1 year+28.58% Since inception+7.50%
Data through 06/27/2017

Quote Details

Previous close$310.89
Open day’s range310.50 – 316.88
Net asset value (NAV)319.65 (06/26/2017)
Daily volume54,390
Average volume (3 months)1,144,107
Data as of 1:59pm ET, 06/28/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+20.29%+16.30%
Expense Gross exp ratio0.47%1.33%
Risk 5 year sharpe ratio0.861.14
Net assets$7.7B$2.9B
Average market cap$16.4B$28.9B
Average P/E20.922.4
Dividend / Share--0.28%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
REGN Regeneron Pharmaceuticals7.97%
CELG Celgene7.66%
GILD Gilead Sciences7.61%
AMGN Amgen7.27%
BIIB Biogen7.10%
VRTX Vertex Pharmaceuticals Inc5.20%
ILMN Illumina Inc4.38%
INCY Incyte Corp4.02%
MYL Mylan NV3.53%
ALXN Alexion Pharmaceuticals Inc3.09%